John R. Stanley

John R. Stanley

Auto-generated profile, based on publicly available information

John R. Stanley

Kutztown University, Pennsylvania

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
KIKen Ishii
Ken Ishii
KYKenji Yoshida
Kenji Yoshida
JSJohn R. Stanley
John R. Stanley
JYJun Yamagami
Jun Yamagami
MAMasayuki Amagai
Masayuki Amagai
AIAkira Ishiko
Akira Ishiko

1 July 1997 in Gene
Verified
Journal Article
Closed access
Ana HurtadoAna Hurtado
Ana Hurtado
JCJonathan P. Clewley
Jonathan P. Clewley
DLDennis Linton
Dennis Linton
RORobert J. Owen
Robert J. Owen
JSJohn Stanley
John Stanley

1 July 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
YHYing-Chao Hsueh
Ying-Chao Hsueh
YWYuzhen Wang
Yuzhen Wang
RRRebecca L. Riding
Rebecca L. Riding
DCDonna E. Catalano
Donna E. Catalano
YLYu-Jung Lu
Yu-Jung Lu
JHJohn E. Harris
John E. Harris

15 August 1992 in FEMS Microbiology Letters
Verified
Journal Article
Open access
PDF file
JSJohn Stanley
John Stanley
NCNamoos Chowdry
Namoos Chowdry
NPNeville Powell
Neville Powell
ETEric John Threlfall
Eric John Threlfall
The copy number and location of the insertion sequence IS200, a mobile DNA element, was established across a collection of Salmonella berta. All strains contained one common site, assumed to be present in the evolutionary ancestor of this serovar. With one exception, all strains, including recent outbreak isolates from the UK and sporadic isolates of world-wide distribution, were representatives of a single genotypic clone which carried three common IS200 insertion sites. This clone has acquired diverse combinations of plasmids, reflecting its actual or recent distribution and host. A single isolate, belonging to a second, minor genotypic clone was characterised by two IS200 insertion sites.

1 October 2009 in Veterinary Dermatology
Verified
Journal Article
Open access
PDF file
JSJohn R. Stanley
John R. Stanley
KIKen Ishii
Ken Ishii
DSDon L. Siegel
Don L. Siegel
APAimee S. Payne
Aimee S. Payne
Autoantibodies in pemphigus foliaceus (PF) and vulgaris (PV) bind to desmoglein (Dsg) 1 and 3, respectively, and cause loss of keratinocyte adhesion. To characterize the pathogenicity and genetics of such antibodies we have used phage display to isolate monoclonal antibodies (mAbs) from patients. PCR is used to clone the heavy and light chain variable region of the peripheral B cells into a vector that creates a phage particle with the antibody expressed on its surface and the cDNA encoding that antibody inside. The library of phage produced from a PF or PV patient are then panned on a plate containing Dsg1 or Dsg3 to isolate clones. The cDNA of each clone is sequenced to characterize the genetics of the expressed mAb. The mAb from each unique clone is tested for pathogenicity either by injecting into normal human skin organ culture or into neonatal mice. Pathogenic antibodies cause typical pemphigus blisters. In both PV and PF patients the heavy chain (VH) genes used for Dsg-binding antibodies are severely restricted. PV and PF patients have both pathogenic and non-pathogenic mAbs. The immunochemical characteristics of the antibodies (including pathogenicity) sort with the VH, not the VL, gene. These monoclonal pathogenic antibodies can be used to screen peptide libraries to find short peptides that block antibody binding. In summary, the antibody response is restricted and, therefore, it may be feasible to target the specific pathogenic antibodies for therapy.